FDA’s National Drug Code (NDC) Directory contains information about finished drug products, unfinished drugs and compounded drug products. Finished drug products Drug establishments are...National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... Code: 16714-0130-01 Description: 1 VIAL in 1 CARTON (16714-130-01) / 1 mL in 1 VIAL Effective Date: Nov. 19, 2019 Product Name Manufacturer NDC Pkg Size Package Pill Marketed Products: Adderall XR Oral Capsule Extended Release 24 Hour 10 MG SHIRE US 54092 -0383 -01 100 $854.75 $8.55 Adderall XR Oral Capsule Extended Release 24 Hour 15 MG SHIRE US 54092 -0385 -01 100 $854.75 $8.55 Packaged in bottles of 250 (NDC 57844-215-52). GALZIN ® Zinc Acetate Capsules (50 mg zinc content) are #1 capsules with orange opaque cap and body, imprinted "93-208." Packaged in bottles of 250 (NDC 57844-208-52). Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). See USP Controlled Room Temperature.The NDC Packaged Code 57844-130-01 is assigned to a package of 100 tablet in 1 bottle of Adderall, a human prescription drug labeled by Teva Pharmaceuticals Usa, Inc.. The product's dosage form is tablet and is administered via oral form. Is NDC 57844-130 included in the NDC Directory?NDC Code(s): 57844-105-01, ... 57844-130-01 Packager: Teva Pharmaceuticals USA, Inc. ADDERALL XR (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine ... National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ...Mar 24, 2022 · NDC 47426-201-01 Rx Only. CINVANTI ® (aprepitant) injectable emulsion. 130 mg/18 mL (7.2 mg/mL) For Intravenous Use Only. Must be refrigerated. Store at 2°C-8°C (36°F-46°F). Do Not Freeze. 1 Sterile Single-Dose Vial Discard Unused Portion. Not For Sale. HERON THERAPEUTICS Amphetamine marketed by Teva Pharmaceuticals USA, Inc. under NDC Code 57844-130-01 NDC Code (s) : 57844-105-01, 57844-117-01, 57844-110-01, 57844-112-01, 57844-115-01, 57844-120-01, 57844-130-01 Packager : Teva Pharmaceuticals USA, Inc. Category : HUMAN PRESCRIPTION DRUG LABEL DEA Schedule : CII Marketing Status : New Drug Application Mar 10, 2022 · Adderall immediate release tablet, Teva, 5 mg, bottle, 100 count, NDC 57844-0105-01 Adderall immediate release tablet, Teva, 7.5 mg, bottle, 100 count, NDC 57844-0117-01 Amphetamine mixed salts immediate release tablet, Mallinckrodt, 10 mg, bottle, 100 count, NDC 00406-8892-01 National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ...National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... 57844-117-01, 57844-120-01, 57844-130-01 Packager: Teva Pharmaceuticals USA, Inc. ADDERALL XR (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate) capsule, extended release National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. ... (16714-130-01) / 1 mL in 1 VIAL ...NDC Code(s): 57844-105-01, ... 57844-130-01 Packager: Teva Pharmaceuticals USA, Inc. ADDERALL XR (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine ... Apr 20, 2022 · Pharmacokinetics. Mixed Salts of a Single Entity Amphetamine Product contain d-amphetamine and l-amphetamine salts in the ratio of 3:1. Following administration of a single dose 10 or 30 mg of Mixed Salts of a Single Entity Amphetamine Product to healthy volunteers under fasted conditions, peak plasma concentrations occurred approximately 3 hours post-dose for both d-amphetamine and l-amphetamine. National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ...Adderall immediate release tablet, Teva, 5 mg, bottle, 100 count, NDC 57844-0105-01 Adderall immediate release tablet, Teva, 7.5 mg, bottle, 100 count, NDC 57844-0117-01 Amphetamine mixed salts immediate release tablet, Mallinckrodt, 10 mg, bottle, 100 count, NDC 00406-8892-01The NDC code 57844-130 is assigned by the FDA to the product Adderall which is a human prescription drug product labeled by Teva Pharmaceuticals Usa, Inc.. The generic name of Adderall is dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate.Product Details Strength 12.5 mg Package Details 100 Tablets/Bottle NDC number 57844-0112-01 View PI Product Details Strength 15 mg Package Details 100 Tablets/Bottle NDC number 57844-0115-01 View PI Product Details Aug 13, 2023 · Amphetamine mixed salts immediate release tablet, Lannett, 30 mg, bottle, 100 count, NDC 00527-1506-37. Amphetamine mixed salts immediate release tablet, Lannett, 7.5 mg, bottle, 100 count, NDC 00527-1501-37. Amphetamine mixed salts immediate release tablet, Rhodes, 10 mg, bottle, 100 count, NDC 42858-0723-01. The initial dosage of Dexamethasone Sodium Phosphate Injection, USP may vary from 0.5 mg/day to 9 mg/day depending on the specific disease entity ... HOW SUPPLIED. Dexamethasone Sodium Phosphate Injection, USP is a sterile, clear, colorless solution, essentially free from visible particles and is supplied as follows: 10 mg per mL - 1 mL Single ...The product is distributed in a single package with assigned NDC code 57844-130-01 100 tablet in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk. SEARCH RESULTS for: 1009145 [RxCUI] (22 results) ShareMar 24, 2022 · NDC 47426-201-01 Rx Only. CINVANTI ® (aprepitant) injectable emulsion. 130 mg/18 mL (7.2 mg/mL) For Intravenous Use Only. Must be refrigerated. Store at 2°C-8°C (36°F-46°F). Do Not Freeze. 1 Sterile Single-Dose Vial Discard Unused Portion. Not For Sale. HERON THERAPEUTICS NDC 42494-416-25. CIV PHENOBARBITAL Sodium Injection, USP. 130 mg/mL R x only. FOR IM OR SLOW IV USE. 25 x 1 mL Vials. Store at 20°-25°C (68°-77°F) [See USP Controlled Room Temperature] DO NOT USE IF DISCOLORED OR CONTAINS A PRECIPITATE. MANUFACTURED FOR: CAMERON PHARMACEUTICALS LLC. GTIN: 00342494416258 SN: 115000433564 EXP: 01-2030 LOT ...National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... 100 tablets Unit of use NDC 72516-011-01 Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). Sep 6, 2023 · The National Drug Code (NDC) Directory is updated daily. Current through: 8/30/2023. NDC Application Programming Interface (API) (Firefox and Chrome recommended) Finished Products Unfinished Products Compounded Products. Requests for more specific information should be submitted in writing or directed to FDA's Freedom of Information Staff at: Food and Drug Administration. Freedom of Information Office, New ... segments of the NDC number, separated by hyphens per FDA website. o In the Open Payments application, this element corresponds to the “ National Drug Code (NDC) of Associated Covered Drug or Biological” field for PY2013 – PY2015 submissions or the “Associated Drug or Biological NDC” field for PY2016 onward submissions. • ProprietaryNameNational Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... May 30, 2023 · NDC 57844-105-01. Adderall ® CII ... NDC:57844-130-01: 100 TABLET in 1 BOTTLE: None: Marketing Information: Marketing Category: Application Number or Monograph Citation: National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ...National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... Mar 10, 2022 · 3/10/2022 Amphetamine Mixed Salts, Immediate-Release Tablets Products Affected - Description Amphetamine mixed salts immediate release tablet, Mylan, 12.5 mg, bottle, 100 count, NDC 00378-4544-01 - discontinued Amphetamine mixed salts immediate release tablet, Mylan, 15 mg, bottle, 100 count, NDC 00378-4545-01 - discontinued Mar 10, 2022 · 3/10/2022 Amphetamine Mixed Salts, Immediate-Release Tablets Products Affected - Description Amphetamine mixed salts immediate release tablet, Mylan, 12.5 mg, bottle, 100 count, NDC 00378-4544-01 - discontinued Amphetamine mixed salts immediate release tablet, Mylan, 15 mg, bottle, 100 count, NDC 00378-4545-01 - discontinued Adderall immediate release tablet, Teva, 5 mg, bottle, 100 count, NDC 57844-0105-01 Adderall immediate release tablet, Teva, 7.5 mg, bottle, 100 count, NDC 57844-0117-01 Amphetamine mixed salts immediate release tablet, Mallinckrodt, 10 mg, bottle, 100 count, NDC 00406-8892-01National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ...NDC Code(s): 13537-450-01, ... 57844-117-01, 57844-120-01, 57844-130-01 ... 57844-130-01 Packager: TEVA PHARMACEUTICALS USA, INC. < previous | page of 50 | next > Why ... Apr 20, 2022 · Pharmacokinetics. Mixed Salts of a Single Entity Amphetamine Product contain d-amphetamine and l-amphetamine salts in the ratio of 3:1. Following administration of a single dose 10 or 30 mg of Mixed Salts of a Single Entity Amphetamine Product to healthy volunteers under fasted conditions, peak plasma concentrations occurred approximately 3 hours post-dose for both d-amphetamine and l-amphetamine. In addition, Janssen CarePath can also investigate specialty pharmacies that may be available to simplify product procurement and billing for healthcare providers. If you have any questions, please call a Janssen CarePath Care Coordinator at 877-CarePath (877-227-3728), Monday-Friday, 8:00 AM to 8:00 PM ET.Adderall immediate release tablet, Teva, 5 mg, bottle, 100 count, NDC 57844-0105-01 Adderall immediate release tablet, Teva, 7.5 mg, bottle, 100 count, NDC 57844-0117-01 Amphetamine mixed salts immediate release tablet, Mallinckrodt, 10 mg, bottle, 100 count, NDC 00406-8892-01Jun 30, 2023 · NP Thyroid oral tablet, Acella, 120 mg bottle, 100 count, NDC 42192-0328-01 NP Thyroid oral tablet, Acella, 15 mg bottle, 100 count, NDC 42192-0327-01 Estimated Resupply Dates Feb 26, 2020 · NDC 42494-416-25. CIV PHENOBARBITAL Sodium Injection, USP. 130 mg/mL R x only. FOR IM OR SLOW IV USE. 25 x 1 mL Vials. Store at 20°-25°C (68°-77°F) [See USP Controlled Room Temperature] DO NOT USE IF DISCOLORED OR CONTAINS A PRECIPITATE. MANUFACTURED FOR: CAMERON PHARMACEUTICALS LLC. GTIN: 00342494416258 SN: 115000433564 EXP: 01-2030 LOT ... 100 tablets Unit of use NDC 72516-011-01 Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ...Adderall immediate release tablet, Teva, 5 mg, bottle, 100 count, NDC 57844-0105-01 Adderall immediate release tablet, Teva, 7.5 mg, bottle, 100 count, NDC 57844-0117-01 Amphetamine mixed salts immediate release tablet, Alvogen, 10 mg, bottle, 100 count, NDC 47781-0176-01National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ...Adderall ® CII (Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product)) Rx onlyAbout NDC. The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs manufactured, prepared, propagated, compounded, or processed by it for commercial distribution. (See Section 510 of the Federal Food, Drug, and Cosmetic Act (Act) (21 U.S.C. § 360)).National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... They are available in bottles of 100 tablets (NDC 57844-130-01). Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).130 Pediarix® VFC DTAP/HepB/IPV: 6 weeks - 6 years 0.5 ml: IM GlaxoSmithKline – SKB NDC: 58160-0811-52 (1 dose syringe) 90723: 110 Pentacel® VFC DTaP/Hib/IPV: 6 weeks - 4 years 0.5 ml: IM Sanofi Pasteur – PMC NDC: 49281-0510-05 (1 dose vial) 90698: 120 Twinrix® VFC VFA HepA/HepB - Adult: 18 years & older 1.0 ml: IM GlaxoSmithKline ... May 11, 2022 · NDC: Methylprednisolone Sodium Succinate for Injection, USP: Packaging Configuration: NDC 43598-127-25: 40 mg Single- Dose Vial: 25 vials per Carton: NDC 43598-129-25: 125 mg Single- Dose Vial: 25 vials per Carton: NDC 43598-128-11 : 500 mg Multi-Dose Vial: 1 vial per Carton: NDC 43598-130-74: 1 g Multi-Dose Vial: 1 vial per Carton Triamcinolone acetonide injectable suspension, USP is a synthetic glucocorticoid corticosteroid with anti-inflammatory action. THIS FORMULATION IS SUITABLE FOR INTRAMUSCULAR AND INTRA-ARTICULAR USE ONLY. THIS FORMULATION IS NOT FOR INTRADERMAL INJECTION. Each mL of the sterile aqueous suspension provides 40 mg triamcinolone acetonide, with 0.66 ...NDC 42494-416-25. CIV PHENOBARBITAL Sodium Injection, USP. 130 mg/mL R x only. FOR IM OR SLOW IV USE. 25 x 1 mL Vials. Store at 20°-25°C (68°-77°F) [See USP Controlled Room Temperature] DO NOT USE IF DISCOLORED OR CONTAINS A PRECIPITATE. MANUFACTURED FOR: CAMERON PHARMACEUTICALS LLC. GTIN: 00342494416258 SN: 115000433564 EXP: 01-2030 LOT ...National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... oral cp24 0115-1487-01 30 each 199.65 amphetamine-dextroamphetamine 10 mg oral tabs 42858-723-01 30 each 21.39 amphetamine-dextroamphetamine 20 mg oral tabs 42858-726-01 30 each 22.53 amphetamine-dextroamphetamine 30 mg oral tabs 57844-130-01 30 each 338.25 atenolol 50 mg oral tabs 65862-169-01 30 each 40.71National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ...NDC:16714-130-01. Triamcinolone acetonide injectable suspension USP, 40 mg per mL. Rx Only Northstar Rx LLC. Carton Label . PRINCIPAL DISPLAY PANEL. NDC:16714-130-25.13. Where do I enter NDC data on electronic claim (ANSI 5010 837P. or ANSI 5010 837I) transactions? Here are general guidelines for including NDC data in an electronic claim: Field Name Field Description Loop ID Segment . Product ID Qualifier Enter . N4. in this field 2410 LIN02 National Drug Code Enter the 11-digit NDC billing format NDC Code(s): 57844-105-01, ... 57844-130-01 Packager: Teva Pharmaceuticals USA, Inc. ADDERALL XR (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine ...National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ...National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... 57844-117-01, 57844-120-01, 57844-130-01 Packager: Teva Pharmaceuticals USA, Inc. ADDERALL XR (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate) capsule, extended release Skip to Main Content; National Library of Medicine. National Library of MedicineIn addition, Janssen CarePath can also investigate specialty pharmacies that may be available to simplify product procurement and billing for healthcare providers. If you have any questions, please call a Janssen CarePath Care Coordinator at 877-CarePath (877-227-3728), Monday-Friday, 8:00 AM to 8:00 PM ET.National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ...Product Name Manufacturer NDC Pkg Size Package Pill Marketed Products: Adderall XR Oral Capsule Extended Release 24 Hour 10 MG SHIRE US 54092 -0383 -01 100 $854.75 $8.55 Adderall XR Oral Capsule Extended Release 24 Hour 15 MG SHIRE US 54092 -0385 -01 100 $854.75 $8.55 NDC Code(s): 57844-105-01, ... 57844-130-01 Packager: Teva Pharmaceuticals USA, Inc. ADDERALL XR (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine ... National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ...NDC Code(s): 13537-450-01, ... 57844-117-01, 57844-120-01, 57844-130-01 ... 57844-130-01 Packager: TEVA PHARMACEUTICALS USA, INC. < previous | page of 50 | next > Why ...Product Name Manufacturer NDC Pkg Size Package Pill Marketed Products: Adderall XR Oral Capsule Extended Release 24 Hour 10 MG SHIRE US 54092 -0383 -01 100 $854.75 $8.55 Adderall XR Oral Capsule Extended Release 24 Hour 15 MG SHIRE US 54092 -0385 -01 100 $854.75 $8.55
National Library of Medicine. REPORT ADVERSE EVENTS | Recalls .... Eyc5of1nj7p
oral cp24 0115-1487-01 30 each 199.65 amphetamine-dextroamphetamine 10 mg oral tabs 42858-723-01 30 each 21.39 amphetamine-dextroamphetamine 20 mg oral tabs 42858-726-01 30 each 22.53 amphetamine-dextroamphetamine 30 mg oral tabs 57844-130-01 30 each 338.25 atenolol 50 mg oral tabs 65862-169-01 30 each 40.71NDC:16714-130-01. Triamcinolone acetonide injectable suspension USP, 40 mg per mL. Rx Only Northstar Rx LLC. Carton Label . PRINCIPAL DISPLAY PANEL. NDC:16714-130-25.NDC Code(s): 57844-105-01, ... 57844-130-01 Packager: Teva Pharmaceuticals USA, Inc. ADDERALL XR (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine ...SEARCH RESULTS for: 1009145 [RxCUI] (22 results) Share Adderall ® CII (Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product)) Rx onlyCanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. ... (16714-130-01) / 1 mL in 1 VIAL ...SEARCH RESULTS for: 687043 [RxCUI] (20 results) ShareThe NDC Packaged Code 57844-130-01 is assigned to a package of 100 tablet in 1 bottle of Adderall, a human prescription drug labeled by Teva Pharmaceuticals Usa, Inc.. The product's dosage form is tablet and is administered via oral form. Is NDC 57844-130 included in the NDC Directory?Call Us. Medical professionals, medical facility employees 855.571.2100. Need help with SupplyManager? 800.422.0280. Accounts Receivable 800.453.5180 Adderall ® CII (Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product)) Rx only National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ...100 tablets Unit of use NDC 72516-011-01 Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).SEARCH RESULTS for: 577957 [RxCUI] (24 results) Share Dec 28, 2022 · NDC:16714-130-01. Triamcinolone acetonide injectable suspension USP, 40 mg per mL. Rx Only Northstar Rx LLC. Carton Label . PRINCIPAL DISPLAY PANEL. NDC:16714-130-25. National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... NDC Code(s): 57844-105-01, ... 57844-130-01 Packager: Teva Pharmaceuticals USA, Inc. ADDERALL XR (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine ...National Library of Medicine. REPORT ADVERSE EVENTS | Recalls ... They are available in bottles of 100 Tablets Unit-of-use NDC 11534-196-01 1000 Tablets NDC 11534-196-03 Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required)..